secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2024-08-01T23:59:59+00:00
Accession:  0001558370-24-010533
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IRADIMED reports record Q2 revenue $17.9M, GAAP EPS $0.38
---------------------------------------------------------

- Revenue of $17.9M, up 11.2% YoY; operating income $5.6M, up 13.4%.
- GAAP diluted EPS $0.38; non-GAAP diluted EPS $0.42 vs $0.36 in Q2 2023.
- Q3 2024 guidance: revenue $18.0-18.2M, GAAP EPS $0.34-0.37.
- FY 2024 reaffirmed: revenue $72-74M, GAAP EPS $1.37-1.47.
- Declares quarterly dividend $0.15/share payable Aug 30, record Aug 20.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000155837024010533/0001558370-24-010533-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000155837024010533/irmd-20240801x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-010533

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer